JPML Consolidates Thyroid Drug Hearing-Loss Suits In Illinois
The U.S. Judicial Panel on Multidistrict Litigation has decided to consolidate 18 suits accusing Horizon Pharmaceuticals Inc. of not telling patients a drug it developed to treat thyroid eye disease can...To view the full article, register now.
Already a subscriber? Click here to view full article